GenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan

Bulletin Express

08/06

GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes:

• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.

• Considering the declaration of an interim dividend, if any.

The notice was issued by Chairman and Executive Director Dr. Qiang Lu on 6 August 2026.

Current board composition: three executive directors (Dr. Qiang Lu, Dr. Jiong Lan, Ms. Zhang Wei), two non-executive directors (Mr. Zhu Jingyang, Ms. Tao Sha) and three independent non-executive directors (Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, Mr. Li Bo).

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1124539406"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1124539406\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1124539406?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 06:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124539406","market":"us","top_or_hot":-1,"title":"GenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan","media":"Bulletin Express","content":"<p>GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes:</p>\n<p>• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.</p>\n<p>• Considering the declaration of an interim dividend, if any.</p>\n<p>The notice was issued by Chairman and Executive Director Dr. Qiang Lu on 6 August 2026.</p>\n<p>Current board composition: three executive directors (Dr. Qiang Lu, Dr. Jiong Lan, Ms. Zhang Wei), two non-executive directors (Mr. Zhu Jingyang, Ms. Tao Sha) and three independent non-executive directors (Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, Mr. Li Bo).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-06 06:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes:</p>\n<p>• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.</p>\n<p>• Considering the declaration of an interim dividend, if any.</p>\n<p>The notice was issued by Chairman and Executive Director Dr. Qiang Lu on 6 August 2026.</p>\n<p>Current board composition: three executive directors (Dr. Qiang Lu, Dr. Jiong Lan, Ms. Zhang Wei), two non-executive directors (Mr. Zhu Jingyang, Ms. Tao Sha) and three independent non-executive directors (Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, Mr. Li Bo).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02595","symbol_name":"劲方医药-B","start_time":0,"source_url":"","article_id":"1124539406","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124539406","pubTimestamp":1785967687,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes: • Reviewing and approving the consolidated interim results for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02595":"劲方医药-B"},"translate_title":"GenFleet Therapeutics 定于 2026 年 8 月 21 日召开董事会会议，批准 2026 年上半年中期业绩和股息计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02595":1},"content_text":"GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes:\n• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.\n• Considering the declaration of an interim dividend, if any.\nThe notice was issued by Chairman and Executive Director Dr. Qiang Lu on 6 August 2026.\nCurrent board composition: three executive directors (Dr. Qiang Lu, Dr. Jiong Lan, Ms. Zhang Wei), two non-executive directors (Mr. Zhu Jingyang, Ms. Tao Sha) and three independent non-executive directors (Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, Mr. Li Bo).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}